- Mark S. Wrighton
Mark Stephen Wrighton Chancellor, Washington University in St. Louis Mark S. Wrighton , Ph.D., was elected the 14 th Chancellor of Washington University in St. Louis in 1995, and serves as its chief executive officer. In the years following his appointment, the University has made significant progress in student quality, campus improvements, resource development, curriculum, and international reputation.
- Mario Capecchi
Mario Capecchi , Ph.D. Distinguished Professor Co-Chairman of Human Genetics Investigator, Howard Hughes Medical Institute
- John Froines
John R. Froines is a chemist and anti-war activist. He is most noted as a member of the Chicago Seven, a group charged with involvement with the riots at the 1968 Democratic Convention in Chicago. Froines, who holds a Ph.D. in Chemistry from Yale, was charged with interstate travel for purposes of inciting a riot and with making incendiary devices. He and Lee Weiner were the only two defendants to be acquitted by the jury on both of the counts charged against them, …
- Elliott Waters Montroll
Elliott Waters Montroll (May 4, 1916 in Pittsburgh, Pennsylvania, USA - December 3, 1983 in Chevy Chase, Maryland, USA) was an American scientist and mathematician. He was awarded a Ph.D. in mathematics at the University of Pittsburgh in 1939, with a thesis "Applications of the characteristic value theory of integral equations' in which he applied integral equations to the study of imperfect gases.
- Joseph Erlanger
Joseph Erlanger (San Francisco, January 5, 1874 - December 5, 1965 in St. Louis, Missouri) was an American physiologist. He won a Nobel Prize in Medicine and Physiology in 1944 for the discovery of different types of nerve fibers.
- Kate Novak
Kate Novak is a fantasy author. She grew up in Pittsburgh, where she received a B.S. in Chemistry from the University of Pittsburgh. She is married to Jeff Grubb. Kate Novak and Jeff Grubb are co-authors of the best-selling "Finder's Stone Trilogy".
- Stephanie Louise Kwolek
Stephanie Kwolek was born on July 31, 1923 in New Kensington, Pennsylvania to John and Nellie Zajdel Kwolek . Stephanie's father died when she was 10, and her mother obtained a job with the Aluminum Company of America to support Stephanie and her brother. Kwolek enrolled in the Carnegie Institute of Technology (the women's college of what is now Carnegie Mellon University) in Pittsburgh in 1942, graduating with a bachelor's degree in chemistry in 1946.
- Myron Tribus
Myron T Tribus (October 30, 1921 -) is perhaps best known as former director of the Center for Advanced Engineering Study at MIT. He headed the center when it published W. Edwards Deming's book, "Out of the Crisis", and became a leading supporter and interpreter of W. Edwards Deming. He is also known in the 1970s for an insightful book called "Rational descriptions, decisions and designs" which popularized Bayesian methods with examples.
- Hing Leung Sham
Hing Leung Sham Ph.D, Sr. VP, Elan Pharmaceuticals (former Abbott) Before joing Elan as Sr VP, Dr Hing Sham was a Director/Distinguished Research Fellow Metabolic Disease Research, Global Pharmaceutical R and D, at Abbott, Dr. Hing Leung Sham , Ph.D received a B.S. in Chemistry from the University of Minnesota, an M.S. in Physical Organic Chemistry from Iowa State University, and a Ph.D in Synthetic Organic Chemistry from the University of Hawaii.
- Bre Millard
Bre Millard US University: United States Military Academy A cadet at West Point, Bre Millard will receive a BS in Chemistry and Life Sciences. She plans to read for an MLitt in International Security Studies at St Andrews, followed by an MA in War Studies at Kings College, London, in preparation for a career in national security policy, with a particular interest in bioterrorism. Raised in Northfield and Mt Hermon, Massachusetts, Bre took up boxing at West Point.
- Dennis Damore
DENNIS DAMORE Dennis Damore is Founder and Senior Director of Crisis Simulations International. Dennis is also President and Chief Operating Officer of Advanced Competitive Strategies, Inc., where has managed and facilitated business war games for executives in Fortune Global 500 companies in a wide variety of industries in North America, Latin America, and Europe. He has also worked as a litigator.
- Pamela A. Simonton
- Scott King
Scott R. King Scott R. King , age 49, is the President and CEO of the Company and one of its founders. Scott R. King , age 49, is the President and CEO of the Company and one of its founders. ( E-mail Scott. ( E-mail Scott. ) He received a B.S. in Chemistry from the University of Chicago in 1977 and an M.A. in Biochemistry from Harvard University in 1978.
- Jay Keasling
Jay Keasling , a chemical engineer by training who has risen to prominence in the burgeoning field of synthetic biology, has been named by Lab Director Steve Chu as the new director of the Physical Biosciences Division (PBD). He succeeds Graham Fleming, who recently became Berkeley Lab’s deputy director. Jay Keasling “I’m excited about the opportunity to lead the division,” said Keasling.
- Dr Cutberto Garza MD
Cutberto Garza , M.D. Cutberto Garza , M.D., the director of the Division of Nutritional Sciences at Cornell University, is known internationally for the key role he has played in understanding the nutritional needs of young children. His research on human lactation and the immunologic components of human milk has provided critical knowledge about human nutrition, and he has taken an active role in raising awareness about breast-feeding as a life-saving factor in developing countries.
- Jim Sherblom
Jim Sherblom Jim Sherblom Managing General Partner, Seaflower Ventures Jim has 20 years experience in senior executive roles in the biopharmaceutical industry and investing in early-stage life science companies. He founded Seaflower Ventures in 1993 to invest his own personal capital and provide hands-on advice to biotech start-ups. Jim is a founder, served for eight years on the Board, and is a past President of the Massachusetts Biotechnology Council (MBC).
- Francis Chen
Mr. Francis Chen Mr. Chen is a co-founder and chairman of Pacific Advantage International, a sales, marketing and technical support organization that assists U.S. and European high-tech companies to establish sales and distribution channels in Asia. He is also a co-founder and board member of Antara Systems that provides a software platform that optimizes online advertising.
- Arnold Speert
Dr. Arnold Speert (Appointed 1985) Ex Officio President Dr. Arnold Speert became the sixth president of William Paterson College on September 1, 1985. He joined the University in 1970 as an assistant professor of chemistry, achieved the rank of full professor in 1980 and served as Associate Dean for Academic Affairs and then VP for Academic Affairs before assuming the presidency.
- Miguel Villarreal Jr
Miguel Villarreal " url="http://www.gunn-lee.com/Attorneys/MiguelVillarreal.aspx"><menuitem id="69" title="&nbsp;Experience" url="http://www.gunn-lee.com/Attorneys/MiguelVillarreal/Experience.aspx" /><menuitem id="105" title="&nbsp;Publications" url="http://www.gunn-lee.com/Attorneys/MiguelVillarreal/Publications.aspx" /><menuitem id="81" title="&nbsp;Personal" url="http://www.gunn-lee.com/Attorneys/MiguelVillarreal/Personal.aspx" /></menuitem><menuitem id="70" title="&nbsp;Rober
- Joe W. Wyse
Joe W. Wyse , Ph.D. President & CEO Dr. Wyse is the President & CEO of Coldstream Laboratories Inc. Dr. Wyse’s 19 year career has focused on various aspects of pharmaceutical, biotechnology, and medical device development, including product development, business development, and intellectual asset management.
- Eric Ross
Eric Ross Eric is a Partner, and Chief Investment Strategist and Associate Director of Research. Eric is a Partner, and Chief Investment Strategist and Associate Director of Research. Prior to joining ThinkEquity Partners LLC, he was the Director of Electronics Research at Investec, a global investment bank with 5,500 employees, directing five analysts and associated staff covering roughly 60 names.
- Charley Geoly
Charley Geoly Charley Geoly is an active member of the firm’s Technology Sector as well as the CEO/Board Services Practice. Based in Menlo Park, Charley’s primary focus is helping medium to large public technology companies find new leaders, including CEOs, presidents and COOs. Charley also manages several global relationships for the firm.
- Devron R. Averett
Devron R. Averett , Ph.D., is Chief Scientific Officer and a co-founder of Anadys Pharmaceuticals, Inc. ( www.anadyspharma.com ). He initially served as Senior Vice President, Research, Development and Medical in 2000 and later as Senior Vice President, Drug Development before he was promoted to Chief Scientific Officer in October 2004.
- Henry Feinberg
Henry Feinberg , joined TCV as a Partner in 2000. He brings to TCV 25 years of Fortune 500 operating and transaction experience. As the Chairman and CEO of Rand McNally, the world's largest global provider of geographic information in print and electronic media, Henry led the charge into the New Economy.
- Paul Gargan
Dr. Gargan joined the Company as Vice President, Business Development and Planning in 1997 and in July 2002 was named Vice President — Business Development. He was previously President and Chief Scientific Officer at American Biogenetic Sciences. Dr. Gargan’s twenty years of experience in the biotechnology industry include five years in research and development and fifteen years in general management specializing in technology, licensing, strategic partnerships and alliance management.
- Joseph M. Quashnock
Dr. Quashnock received his BS in chemistry and biology from the University of Dayton and MS and PhD in biochemistry (enzyme structure and function) from the University of Notre Dame. He has over thirty years experience in directing and administering medical laboratories with the U.S. Army Medical Department, National Health Laboratories, Laboratory Corporation of America, and the specialized newborn screening laboratory of Pediatrix Screening (formerly Neo Gen Screening).
- William H. Rastetter
Bill Rastetter joined Venrock in 2006 and comes to Venrock from Biogen Idec, where he was most recently executive chairman. Bill joined Idec Pharmaceuticals at its founding and grew it to a multi-billion-dollar market valuation company, while serving as president and CEO. Prior to Idec, he was Director of Corporate Ventures at Genentech, Inc. and served in a scientific capacity at Genentech.
- Ann Savoca
Ann C. Savoca Corporate Vice President Research and Development National Starch and Chemical Company Ann is Corporate Vice President, Research and Development for National Starch and Chemical Company and a member of the Imperial Chemical Industries technology executive, responsible for ICI global applied research. Ann joined National Starch in 1997 as Director of Corporate Research and became Divisional Vice President for Corporate Research and Science Support in 2000.
- Tammy Grimm
Tammy (Kohnen) Grimm joined the Federal Reserve Bank of St. Louis in 2004. She is currently responsible for coordinating the use of instructional design project resources for the Center. Tammy also serves as an educational development specialist on the System's Law Enforcement Training Advisory Council (LETAC) and helps support the LMS though her role as the Center's FedLearn Coordinator.
- Gordon E. Moore
Gordon Moore is co-founder of Intel Corporation and Chairman Emeritus of the Corporation's Board of Directors. Prior to Intel, Gordon co-founded Fairchild Semiconductor in 1957. A California native, Moore earned his B.S. in chemistry from the University of California at Berkeley and his Ph.D. in Chemistry and Physics from the California Institute of Technology. In 1968 he co-founded Intel, serving initially as executive vice president.
- Sidney M. Morris
Dr. Morris graduated summa cum laude with a BS in Chemistry from the University of Texas at Austin in 1968 and received his PhD in Biochemistry from the University of California at Berkeley in 1975. He then worked as a Postdoctoral Fellow in Physiological Chemistry at the University of Wisconsin from 1975-1978. From 1978-1982 Dr. Morris served as a Research Associate at the University of Wisconsin and Case Western Reserve University.
- Laurie Leshin
Dr. Leshin is a cosmochemist primarily interested in deciphering the record of water on objects in our solar system. She has more than 15 years experience performing quantitative analyses of extraterrestrial rocks in the laboratory, and participating in NASA flight projects. A primary part of her research involves using meteorites from Mars to assess the history of water and the potential for life on the red planet.
- Richard Heyman
Richard A. Heyman , PhD Senior Vice President, Drug Discovery Rich Heyman joined Kalypsys Inc. as Senior Vice President of Drug Discovery in September 2006. He was formerly Senior Vice President of Metabolic Diseases and site head at the San Diego research site of Exelixis Inc. In 1999, he co-founded X-Ceptor Therapeutics, a drug discovery company that focused on the identification of new therapeutic agents targeting nuclear receptors for the treatment of metabolic diseases.
- Cesar Castro
InnoCentive (www.innocentive.com) is an internet based global scientific community serving companies such as Procter & Gamble, Dow Chemical, BASF, and Eli Lilly. Born in Colombia, South America. Intersted in meeting R&D executives from the Global Fortune 500 in Chemicals, Plastics, Pharmaceuticals, Oil & Gas, Consumer Products, Automotive Industries. Interested in meeting fellow latin american working professionals.
- Joseph C. Salamone
Joseph C. Salamone , Ph.D. Dr. Joseph C. Salamone , is Chief Technology Officer at Rochal Industries, LLP. He has previous served as a vice president overseeing various research functions at Bausch & Lomb since 1997, is Chair of AIMBE's Industry Council. He was named an AIMBE Fellow in 2006.
- Q. Todd Dickinson
Mr. Dickinson is a member of the board of directors of the Intellectual Property Owners Association and the Council of the American Bar Association Intellectual Property Law Section. He is also the ABA delegate to the World Intellectual Property Organization. In 2004 and 2005, he was named one of “The 50 Most Influential People in Intellectual Property” by Managing Intellectual Property magazine, and is one of the Lawdragon 500 Leading Lawyers in America.
- Suzanne M. Shema
Suzanne M. Shema has served as our Senior Vice President, Intellectual Property and Legal Affairs since April 2003, and as our Secretary since June 2004. Previously, Ms. Shema served as our Vice President, Intellectual Property and Legal Affairs from December 2001 to April 2003 and as Senior Director, Intellectual Property from May 2001 to December 2001. From February 2000 to May 2001, Ms. Shema served as General Counsel at aQuantive, Inc., an Internet advertising company.
- Lee Peterman
Lee received an MS degree in Paper Science and Engineering from the Institute of Paper Science and Technology, and a BS in Chemistry from the University of Wisconsin. His work with Kalypso: Lee manages large-scale business transformation programs for clients. His extensive product development process experience, coupled with his strong IT background, enables Lee to assist clients with both the business strategy and operational tactics needed to ensure program success.
- James A. Wylie
James A. Wylie, Jr . Mr. Wylie has been a director of the Company since January 2003, at which time he also became the Company's president and chief executive officer. Prior to joining the Company, Mr. Wylie acted as a consultant from 1994 through 2002, providing strategic advisory and interim executive management services to institutional investors and operating companies in the medical device, health care, chemical and telecommunications industries.
- Philip E. Yeske
Dr. Philip E. Yeske President and CEO, Fluorous Technologies Dr. Philip E. Yeske received a B.S. in Chemistry from Allegheny College in 1985 and a doctorate from Emory University in 1990 under the direction of Professor Albert Padwa. After working with Professor Dennis Curran at the University of Pittsburgh as a Postdoctoral Fellow, Dr. Yeske joined Bayer Corporation in 1991.